|This article needs additional citations for verification. (February 2008)|
The Fontan procedure is a palliative surgical procedure used in children with complex congenital heart defects. It involves diverting the venous blood from the right atrium to the pulmonary arteries without passing through the morphologic right ventricle; i.e., the systemic and pulmonary circulations are placed in series with the functional single ventricle. It was initially described in 1971 by Dr. Francois Marie Fontan (1929 – ) from Bordeaux, France, and later in 1973 by Dr. Guillermo Kreutzer from Buenos Aires, Argentina (1934 – ) separately as a surgical treatment for tricuspid atresia. 
The Fontan procedure is used in pediatric patients who possess only a single functional ventricle, either due to lack of a heart valve (e.g. tricuspid or mitral atresia), an abnormality of the pumping ability of the heart (e.g. hypoplastic left heart syndrome or hypoplastic right heart syndrome), or a complex congenital heart disease where a bi-ventricular repair is impossible or inadvisable. The single ventricle is doing nearly twice the expected amount of work because it has to pump blood for the body and lungs. Patients typically present as neonates with cyanosis or congestive heart failure. Fontan completion is usually carried out when the patient is 2-5 years of age, but is also performed before 2 years of age. 
After Fontan completion, blood must flow through the lungs without being pumped by the heart. Therefore, children with high pulmonary vascular resistance may not tolerate a Fontan procedure. Often, cardiac catheterization is performed to check the resistance before proceeding with the surgery. This is also the reason a Fontan procedure cannot be done immediately after birth; the pulmonary vascular resistance is high in utero and takes months to drop.
There are three variations of the Fontan procedure:
- Atriopulmonary connection (the original technique)
- Intracardiac total cavopulmonary connection (lateral tunnel)
- Extracardiac total cavopulmonary connection
The Fontan is usually done as a two staged repair.
The first stage, also called a Bidirectional Glenn procedure or Hemi-Fontan (see also Kawashima procedure), involves redirecting oxygen-poor blood from the top of the body to the lungs. That is, the pulmonary arteries are disconnected from their existing blood supply (e.g. a shunt created during a Norwood procedure, a patent ductus arteriosus, etc.). The superior vena cava (SVC), which carries blood returning from the upper body, is disconnected from the heart and instead redirected into the pulmonary arteries. The inferior vena cava (IVC), which carries blood returning from the lower body, continues to connect to the heart.
The second stage, also called Fontan completion, involves redirecting the blood from the IVC to the lungs. At this point, the oxygen-poor blood from upper and lower body flows through the lungs without being pumped (driven only by the pressure that builds up in the veins). This corrects the hypoxia and leaves the single ventricle responsible only for supplying blood to the body.
In the short term, children can have trouble with pleural effusions (fluid building up around the lungs). This can require a longer stay in the hospital for drainage with chest tubes. To address this risk, some surgeons make a fenestration from the venous circulation into the atrium. When the pressure in the veins is high, some of the oxygen-poor blood can escape through the fenestration to relieve the pressure. However, this results in hypoxia, so the fenestration may eventually need to be closed by an interventional cardiologist.
In the long term, children can have trouble with atrial flutter and atrial fibrillation because of scarring in the atrium, especially if the connection of the IVC to pulmonary arteries involved an intracardiac baffle (instead of an extracardiac conduit). This sometimes requires treatment such as radiofrequency ablation. Other long-term risks include protein-losing enteropathy and chronic renal insufficiency, although understanding of these risks is still incomplete. Some patients require long-term blood thinners. Four case reports of hepatocellular carcinoma following the Fontan Procedure were reported by physicians at the Mayo Clinic in the New England Journal of Medicine (368;18 pp 1756–1757). This group of patients may warrant screening for this malignancy, especially if the alpha-fetoprotein level is elevated.
The Fontan procedure is palliative — not curative — but in many cases it can result in normal or near-normal growth, development, exercise tolerance, and good quality of life. In 20-30% cases, patients will eventually require heart transplantation.
- Fontan F, Baudet E (1971). "Surgical repair of tricuspid atresia". Thorax 26 (3): 240–8. doi:10.1136/thx.26.3.240. PMC 1019078. PMID 5089489.
- Kreutzer G, Galindez H, Bono H, (1973). "An operation for the correction of tricuspid atresia.". The Journal of Thoracic and Cardiovascular Surgery 66 (3): 613–21. PMID 4518787.
- O'Leary PW. (2002). "Prevalence, clinical presentation and natural history of patients with single ventricle.". Progress in Pediatric Cardiology 16: 31–38. doi:10.1016/s1058-9813(02)00042-5.
- Hirsch JC, Goldberg C, Bove EL; et al. (2008). "Fontan operation in the current era: a 15-year single institution experience.". Annals of Surgery 248: 402–410.
- Anderson PAW, Sleeper LA, Mahony L; et al. (2008). "Contemporary outcomes after the Fontan procedure: A Pediatric Heart Network multicenter study.". Journal of the American College of Cardiology 52 (2): 85–93.
- Leval, Marc R de (2005). "The Fontan circulation: a challenge to William Harvey?". Nature Clinical Practice Cardiovascular Medicine 2 (4): 202–208. doi:10.1038/ncpcardio0157. PMID 16265484.
- Mair DD, Puga FJ, Danielson GK (November 1992). "Late functional status of survivors of the Fontan procedure performed during the 1970s". Circulation 86 (5 Suppl): II106–9. PMID 1423987.
- Behrman, Richard E.; Robert M. Kliegman; Hal B. Jenson (2004). Nelson Textbook of Pediatrics (17th ed.). Saunders. ISBN 0-7216-9556-6.
- Overview of single ventricle lesions from Cincinnati Children's Heart Center
- The Pediatric Heart Network Fontan Cross-sectional Study
- The Australia and New Zealand Fontan Registry